Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism
Status:
Unknown status
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The aim of the present study was to assess the effects of low-dose (25mg) prolonged
administration (in 6 hours) of tissue type plasminogen activator (tPA) on in-hospital
mortality and outcomes in patients with massive PE.
Phase:
Phase 4
Details
Lead Sponsor:
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital